Amber Labs — FY26 Financial Dashboard

YTD revenue

£9.91m

Q1 £5.05m · Q2 £4.86m

YTD gross profit

£2.71m

27.4% margin

YTD EBITDA

£86.9k

0.9% margin

YTD reported EBITDA

£494.7k

5.0% margin

YTD adjusted EBITDA

£310.4k

3.1% margin

Q1 to Q2 adjusted EBITDA bridge

Start / end Favourable Adverse

Key ratios — Q1 vs Q2

Q1 margins Q2 margins Revenue (£m)

Margin analysis

Reported gross margin

30.4%24.2%

-6.2pp Q1→Q2

CoA ratio

5.2%7.0%

+1.8pp Q1→Q2

Contribution margin

22.9%14.5%

-8.4pp Q1→Q2

Overhead ratio

14.4%18.3%

+3.9pp Q1→Q2

Adj EBITDA margin

8.4%-2.4%

-10.8pp Q1→Q2

Indexed revenue

£5.14m£5.18m

+0.7% Q1→Q2

Amber Labs EBITDA

Line item	Q1	Q2	YTD
Sales	5,050,086	4,855,349	9,905,435
Total turnover	5,050,086	4,855,349	9,905,435
Bonus	0	19,818	19,818
Customer rebate	39,598	130,565	170,163
Direct expenses	1,354,205	1,195,147	2,549,352
Direct wages	1,894,960	2,078,759	3,973,719
Direct wages capitalised	(119,417)	(130,936)	(250,352)
Employer national insurance	264,130	292,884	557,014
Pension costs	53,286	62,088	115,374
Project expenses	25,965	32,148	58,113
Total cost of sales	3,512,728	3,680,473	7,193,201
Gross profit	1,537,357	1,174,876	2,712,234
Total costs of acquisition	260,813	339,015	599,828
Contribution	1,276,544	835,861	2,112,406
Total staff costs	360,737	411,655	772,391
Consulting & professional fees	229,053	301,775	530,828
Total IT costs	83,256	88,862	172,118
Total office costs	16,131	17,333	33,464
Total entertainment	1,024	41,567	42,591
Total vehicle & travel	37,602	27,374	64,976
Total other costs	1,313	60	1,373
Total overheads	729,115	888,626	1,617,741
Reported EBITDA	547,429	(52,765)	494,664
Capitalisation add-backs	(198,197)	(209,574)	(407,771)
EBITDA	349,232	(262,339)	86,893
Exceptional items	77,000	146,535	223,535
Adjusted EBITDA	426,232	(115,803)	310,429

Amber Labs balance sheet - summary

£	28 Feb 26	31 Jan 26	31 Dec 25	30 Nov 25	31 Oct 25	30 Sep 25
Fixed assets
Fixed assets	3,484	3,608	3,746	3,863	4,285	4,150
Intangibles	3,565,000	3,494,289	3,424,316	3,355,427	3,287,139	3,220,529
Total fixed assets	3,568,485	3,497,897	3,428,061	3,359,289	3,291,423	3,224,679
Current assets
Bank	514,485	287,354	544,483	71,730	85,458	59,181
AR	1,806,242	1,830,471	594,288	2,628,283	1,389,343	1,410,450
Accrued income	550,879	528,328	461,165	345,678	1,132,615	595,411
Other AR	158,222	158,222	158,222	158,222	158,222	157,742
Prepayments	276,270	194,446	214,111	208,986	186,455	174,862
Total current assets	3,306,098	2,998,822	1,972,269	3,412,899	2,952,093	2,397,647
Current liabilities
AP	(1,288,027)	(1,087,353)	(1,197,274)	(1,268,193)	(1,479,046)	(1,518,738)
Accruals	(514,934)	(469,013)	(385,025)	(356,045)	(360,835)	(284,316)
Salaries and pension	(61,119)	(56,083)	(89,144)	(41,673)	(46,922)	(38,025)
Other AP	3,264	2,961	(113)	(377)	(2,260)	2,037
DLA	848,938	1,054,792	956,196	807,183	762,728	742,772
PAYE	(683,468)	(895,058)	(881,348)	(529,469)	(576,533)	(251,955)
Corporation tax	(150,660)	(150,660)	(150,660)	(150,660)	(150,660)	(101,701)
VAT	(1,778,648)	(1,590,375)	(1,377,602)	(1,321,438)	(935,381)	(895,803)
Total current liabilities	(3,624,653)	(3,190,789)	(3,124,970)	(2,860,671)	(2,788,909)	(2,345,727)
Long-term liabilities
Loan	(1,456,281)	(1,505,655)	(1,550,575)	(1,232,059)	(1,512,812)	(1,819,584)
Invoice financing	(1,227,989)	(1,224,989)	(192,011)	(1,964,111)	(1,282,796)	(908,802)
Total long-term liabilities	(2,684,270)	(2,730,645)	(1,742,586)	(3,196,170)	(2,795,608)	(2,728,386)
Net assets	565,659	575,286	532,775	715,348	659,000	548,212
Equity
OSC	120	120	120	120	120	120
CY P&L	80,597	90,224	47,712	230,286	173,937	63,150
Retained earnings	484,942	484,942	484,942	484,942	484,942	484,942
Total equity	565,659	575,286	532,775	715,348	659,000	548,212

Amber Labs cash flow L5M

Start / end Favourable Adverse

Cash flow statement

£	YTD (L5M)	28 Feb 26	31 Jan 26	31 Dec 25	30 Nov 25	31 Oct 25
Net profit / (loss)	17,447	(9,627)	42,511	(182,573)	56,348	110,788
Capitalisation	(343,806)	(70,587)	(69,836)	(68,772)	(67,866)	(66,745)
Interest	388,632	32,902	46,300	91,740	119,735	97,951
Exceptional items	208,535	66,318	54,317	25,900	31,000	31,000
EBITDA	270,808	19,006	73,293	(133,705)	139,218	172,994
Working capital movements
AR	(76,605)	27,229	(203,204)	261,895	(557,626)	395,101
Accrued income	44,533	(22,550)	(67,164)	(115,487)	786,937	(537,204)
AP	(230,711)	200,674	(109,922)	(70,919)	(210,853)	(39,691)
Accruals	230,618	45,921	83,988	28,980	(4,790)	76,519
Other AR and prepayments	(101,888)	(81,824)	19,665	(5,125)	(22,531)	(12,073)
Other AP	21,867	4,733	(36,135)	47,208	(7,132)	13,193
Δ changes in working capital	(112,187)	174,182	(312,772)	146,553	(15,995)	(104,154)
Cash from operations	158,622	193,188	(239,479)	12,848	123,223	68,840
Corporation tax	48,960	0	0	0	0	48,960
CFADS	207,581	193,188	(239,479)	12,848	123,223	117,800
Financing
VAT	882,844	188,273	212,773	56,160	386,057	39,578
PAYE	431,514	(211,590)	13,710	351,879	(47,064)	324,578
Loans	(751,935)	(82,276)	(91,220)	226,700	(400,488)	(404,724)
DLA	(106,166)	205,854	(98,596)	(149,013)	(44,456)	(19,955)
Exceptional costs	(208,535)	(66,318)	(54,317)	(25,900)	(31,000)	(31,000)
Cash from financing	456,258	33,943	(17,650)	459,500	(136,951)	(91,523)
Opening cash	59,181	287,354	544,483	71,730	85,458	59,181
Movement	455,304	227,131	(257,129)	472,753	(13,728)	26,277
Closing cash	514,485	514,485	287,354	544,483	71,730	85,458

Financials

Amber Labs — FY26 YTD summary